Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 2×

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene

Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722

A second endogenous cannabinoid that modulates long-term potentiation

Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077

REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336

The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?

Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913

Involvement of the endocannabinoid system in drug addiction

Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 601

THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY

de Fonseca, F. R., del Arco, I., Bermúdez‐Silva, F. J., Bilbao, A., Cippitelli, A., & Navarro, M. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh110 · Cited by 419

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Cohen, C., Perrault, G., Voltz, C., Steinberg, R., & Soubrié, P. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00018 · Cited by 396

Endocannabinoid Hedonic Hotspot for Sensory Pleasure: Anandamide in Nucleus Accumbens Shell Enhances ‘Liking’ of a Sweet Reward

Mahler, S. V., Smith, K. S., & Berridge, K. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301376 · Cited by 377

Cannabinoids, opioids and eating behavior: The molecular face of hedonism?

Cota, D., Tschöp, M. H., Horvath, T. L., & Levine, A. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.10.004 · Cited by 330

Endogenous cannabinoid system as a modulator of food intake

Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 323

Synergistic interactions between cannabinoid and opioid analgesics

Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305

Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 294

Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Neuronal Populations in Adult Rats

Ellgren, M., Spano, S., & Hurd, Y. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301127 · Cited by 292

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms?a review of recent preclinical data

Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 288

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

Fantegrossi, W. E., Moran, J. H., Radominska-p, A., & Prather, P. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.017 · Cited by 261

ΔFosB Induction in Striatal Medium Spiny Neuron Subtypes in Response to Chronic Pharmacological, Emotional, and Optogenetic Stimuli

Lobo, M. K., Zaman, S., Damez-Werno, D. M., Koo, J. W., Bagot, R. C., DiNieri, J. A., Nugent, A., Finkel, E., Chaudhury, D., Chandra, R., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1875-13.2013 · Cited by 245

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)

Cohen, C., Perrault, G., Griebel, G., & Soubrié, P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300541 · Cited by 251

The endocannabinoid system in brain reward processes

Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 251

The endogenous opioid system: A common substrate in drug addiction

Trigo, J. M., Martín‐García, E., Berrendero, F., Robledo, P., & Maldonado, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.011 · Cited by 250

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence

Castañé, A., Valjent, E., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00118-1 · Cited by 242

The endocannabinoid system: emotion, learning and addiction

Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 233

Self-administration of ?9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

Justinová, Z., Tanda, G., Redhi, G. H., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1484-0 · Cited by 227

Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol

Berrendero, F., & Maldonado, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 225

Cannabinoid CB1 receptors control conditioned drug seeking

Vries, T. J. D., & Schoffelmeer, A. N. M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.002 · Cited by 219

Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., & Manzanares, J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.003 · Cited by 218

Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions

Barrot, M., Sesack, S. R., Georges, F. E., Pistis, M., Hong, S., & Jhou, T. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3370-12.2012 · Cited by 229

Marijuana and the Cannabinoids

ElSohly, M. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-947-9 · Cited by 219

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

Scavone, J. L., Sterling, R. C., & Van Bockstaele, E. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.034 · Cited by 209

Cannabinoid Addiction: Behavioral Models and Neural Correlates

Maldonado, R. J., & de Fonseca, F. R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

Vries, T. J. D., Homberg, J. R., Binnekade, R., Raasø, H. S., & Schoffelmeer, A. N. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1422-1 · Cited by 197

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.

Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A. L., & Gessa, G. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.006 · Cited by 194

Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings

Morgan, C. J. A., Das, R., Joye, A., Curran, H. V., & Kamboj, S. K. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.011 · Cited by 194

The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in Rats

Solinas, M., Panlilio, L. V., Antoniou, K., Pappas, L., & Goldberg, S. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047928 · Cited by 194

Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia

Mátyás, F., Yanovsky, Y., Mackie, K., Kelsch, W., Misgeld, U., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.005 · Cited by 197

CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors

Houchi, H., Babovic, D., Pierrefiche, O., Ledent, C. A., Daoust, M., & Naassïla, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300568 · Cited by 181

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors

Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188

Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats

Economidou, D., Mattioli, L., Cifani, C., Perfumi, M. C., Massi, M., Cuomo, V., Trabace, L., & Ciccocioppo, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0199-9 · Cited by 169

Molecular and cellular basis of cannabinoid and opioid interactions

Viganò, D., Rubino, T., & Parolaro, D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.021 · Cited by 167

Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference

Hansson, A. C., Bermúdez‐Silva, F. J., Malinen, H., Hyytiä, P., Sánchez-Vera, I., Rimondini, R., de Fonseca, F. R., Kunos, G., Sommer, W. H., & Heilig, M. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301034 · Cited by 167

Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

Williams, C. M., & Kirkham, T. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00694-3 · Cited by 157

Emerging Evidence for Cannabis' Role in Opioid Use Disorder

Wiese, B. M., & Wilson‐Poe, A. R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0022 · Cited by 156

Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling

Wenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 161

Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats

Braida, D., Iosuè, S., Pegorini, S., & Sala, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.043 · Cited by 152

Prenatal Cannabis Exposure Increases Heroin Seeking with Allostatic Changes in Limbic Enkephalin Systems in Adulthood

Spano, M. S., Ellgren, M., Wang, X., & Hurd, Y. L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.073 · Cited by 154

Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice

Naassïla, M., Pierrefiche, O., Ledent, C. A., & Daoust, M. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.002 · Cited by 150

Absence of Δ-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice

Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H., Valverde, O., & Maldonado, R. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09499.2001 · Cited by 141

Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol‐seeking behavior in rats

Cippitelli, A., Bilbao, A., Hansson, A. C., del Arco, I., Sommer, W. H., Heilig, M. A., Massi, M., Bermúdez‐Silva, F. J., Navarro, M., Ciccocioppo, R., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04056.x · Cited by 143

Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens

Zangen, A., Ikemoto, S., Zadina, J. E., & Wise, R. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07225.2002 · Cited by 138

Self-administration of cannabinoids by experimental animals and human marijuana smokers

Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137

Molecular biology of cannabinoid receptors

Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 138

The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction

López‐Moreno, J. A., González‐Cuevas, G., Moreno, G., & Navarro, M. A. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00105.x · Cited by 132

Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in rats

Fattore, L., Spano, M. S., Cossu, G., Deiana, S., & Fratta, W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02607.x · Cited by 128

Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens

Pickel, V. M., Chan, J., Kearn, C. S., & Mackie, K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20881 · Cited by 128

Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence

Cooper, Z. D., & Haney, M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782752 · Cited by 127

Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential

Tai, S., & Fantegrossi, W. E. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0014-y · Cited by 134

Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade

Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300454 · Cited by 125

Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core

Schoffelmeer, A. N. M., Hogenboom, F., WARDEH, G., & Vries, T. J. D. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.05.019 · Cited by 124

Advances in the field of cannabinoid–opioid cross‐talk

Robledo, P., Berrendero, F., Ozaita, A., & Maldonado, R. J. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00107.x · Cited by 121

Mechanisms Underlying Sex Differences in Cannabis Use

Calakos, K. C., Bhatt, S., Foster, D. W., & Cosgrove, K. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0174-7 · Cited by 133

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors

Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119

Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?

Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119

Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway

Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 122

Ghrelin and food reward: The story of potential underlying substrates

Skibicka, K. P., & Dickson, S. L. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.016 · Cited by 122

Role of the endocannabinoid system in drug addiction

Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 118

Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats

Forget, B., Hamon, M., & Thiébot, M.-H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0015-6 · Cited by 116

Endocannabinoid system and alcohol addiction: Pharmacological studies

Colombo, G., SERRA, S., VACCA, G., Carai, M. A. M., & GESSA, G. L. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.022 · Cited by 114

Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers

Haney, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301243 · Cited by 113

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole – LH 21

Pavón, F. J., Bilbao, A., Hernández‐Folgado, L., Cippitelli, A., Jagerovic, N., Abellán, G., Rodríguez-Franco, M. I., Serrano, A., Macías, M., de Heras, R. G., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.029 · Cited by 115

Endocannabinoid system and opioid addiction: Behavioural aspects

Fattore, L., Deiana, S., Spano, S., Cossu, G., Fadda, P., Scherma, M., & Fratta, W. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.031 · Cited by 113

Signaling via CNS cannabinoid receptors

Mackie, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.022 · Cited by 112

The opioid antagonist naltrexone reduces the reinforcing effects of ? 9 -tetrahydrocannabinol (THC) in squirrel monkeys

Tanda, G., Munzar, P., Goldberg, S. R., & Justinova, Z. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1693-6 · Cited by 111

The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)

Ward, S. J., & Dykstra, L. A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00010 · Cited by 111

An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives

Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110

A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions

Orío, L., Edwards, S., George, O., Parsons, L. H., & Koob, G. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-09.2009 · Cited by 111

Pharmacotherapy for Cannabis Dependence

Vandrey, R. G., & Haney, M. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00001 · Cited by 109

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction

Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Seely, K. A., Brents, L. K., Franks, L. N., Rajasekaran, M., Zimmerman, S. M., Fantegrossi, W. E., & Prather, P. L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.046 · Cited by 103

Synthetic Pot: Not Your Grandfather’s Marijuana

Ford, B. M., Tai, S., Fantegrossi, W. E., & Prather, P. L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.003 · Cited by 112

Molecular mechanisms of placebo responses in humans

Peciña, M., & Zubieta, J.-K. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.164 · Cited by 103

Endocannabinoid system involvement in brain reward processes related to drug abuse

Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 102

FAAH selectively influences placebo effects

Peciña, M., Martínez-Jauand, M., Hodgkinson, C. A., Stohler, C. S., Goldman, D. A., & Zubieta, J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.124 · Cited by 96

Cannabinoid Agonists but not Inhibitors of Endogenous Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin in Rats

Solinas, M., Panlilio, L. V., Tanda, G., Makriyannis, A., Matthews, S. A., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300754 · Cited by 103

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

Viganò, D., Valenti, M., Cascio, M. G., Marzo, V. D., Parolaro, D., & Rubino, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03645.x · Cited by 97

Signal Transduction via Cannabinoid Receptors

Dalton, G. D., Bass, C. E., Horn, C. V., & Howlett, A. C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824615 · Cited by 94

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the rat

Spano, M. S., Fattore, L., Cossu, G., Deiana, S., Fadda, P., & Fratta, W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705932 · Cited by 95

Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat Brain

Viganò, D., Cascio, M. G., Rubino, T., Fezza, F., Vaccani, A., Marzo, V. D., & Parolaro, D. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300117 · Cited by 95

Why Should We Keep the Cerebellum in Mind When Thinking About Addiction?

Miquel, M., Toledo‐Cárdenas, M. R., García, L. I., Coria‐Ávila, G. A., & Manzo, J. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010026 · Cited by 96

Endocannabinoid-mediated synaptic plasticity and addiction-related behavior

Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92

In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection

Marshell, R., Kearney-Ramos, T. E., Brents, L. K., Hyatt, W. S., Tai, S., Prather, P. L., & Fantegrossi, W. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.010 · Cited by 90

Rimonabant: The first therapeutically relevant cannabinoid antagonist

Carai, M. A. M., Colombo, G., & Gessa, G. L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.017 · Cited by 90

Bidirectional regulation of mu‐opioid and CB1‐cannabinoid receptor in rats self‐administering heroin or WIN 55,212‐2

Fattore, L., Viganò, D., Fadda, P., Rubino, T., Fratta, W., & Parolaro, D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05470.x · Cited by 89

Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study

Pistis, M., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02019.x · Cited by 88

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers

Horder, J., Harmer, C. J., Cowen, P. J., & McCabe, C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000453 · Cited by 89

Cannabis: A Treasure Trove or Pandora's Box?

Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93

Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats

Fattore, L., Spano, S., Cossu, G., Deiana, S., Fadda, P., & Fratta, W. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.022 · Cited by 87

The Role of the Ghrelin System in Drug Addiction

Zallar, L. J., Farokhnia, M., Tunstall, B. J., Vendruscolo, L. F., & Leggio, L. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.08.002 · Cited by 87

Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future

Panagis, G., Mackey, B., & Vlachou, S. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00092 · Cited by 87

Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors

Canals, M., & Milligan, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710300200 · Cited by 86

Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

Justinová, Z., Munzar, P., Panlilio, L. V., Yaşar, S., Redhi, G. H., Tanda, G., & Goldberg, S. R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.21 · Cited by 86

Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment

Scavone, J. L., Sterling, R. C., Weinstein, S. P., & Bockstaele, E. J. V. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12044.x · Cited by 85

Uso terapêutico dos canabinoides em psiquiatria

Crippa, J. A. S., Zuardi, A. W., & Hallak, J. E. C. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500009 · Cited by 93

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998) · NeuroReport · doi:10.1097/00001756-199810260-00012 · Cited by 152

Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats

Navarro, M., Carrera, M. R. A., del Arco, I., Trigo, J. M., Koob, G. F., & de Fonseca, F. R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.022 · Cited by 34

Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

Nieto, M. M., Pommier, B., Tzavara, E. T., Caneparo, A., Nascimento, S. D., Fur, G. L., Roques, B. P., & Noble, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703990 · Cited by 111

Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.

Lichtman, A. H., Sheikh, S. M., Loh, H. H., & Martin, B. R. (2001) · PubMed · Cited by 156

Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway

Caillé, S., & Parsons, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300848 · Cited by 122